首页 | 本学科首页   官方微博 | 高级检索  
     

静脉注射与13服MTX治疗银屑病临床疗效观察
引用本文:罗权 李常兴 何玉清 林玲 黄振明 张锡宝. 静脉注射与13服MTX治疗银屑病临床疗效观察[J]. 中国皮肤性病学杂志, 2006, 20(7): 416-417
作者姓名:罗权 李常兴 何玉清 林玲 黄振明 张锡宝
作者单位:广州市皮肤病防治所,广东广州510095
基金项目:广东省医学科学技术研究基金(A2004581)
摘    要:
目的评价MTX治疗银屑病的两种给药方案的疗效和安全性。方法将68例银屑病患者随机分为两组。口服组:MTX片2.5-5.0mg口服,12 h 1次,1周内连续3次。注射组:MTX注射液7、5~15.0mg静滴,每周1次。两组疗程均为4周。结果口服组与注射组的有效率分别为87.1%和81.1%,有效率比较差异无显著性(P〉0.05)。两种方法治疗前后PASI评分差异无显著性。且口服组较注射组不良反应发生率低。结论MTX治疗银屑病的两种给药方案均有确切疗效,但口服给药副作用更少。

关 键 词:银屑病 甲氨蝶呤
文章编号:1001-7089(2006)07-0416-02
收稿时间:2005-10-08
修稿时间:2005-10-082005-12-31

Observation of Clinical Efficacy on Oral or IV MTX in Treatment of Psoriasis
LUO Quan,LI Chang-xing,HE Yu-qing,et al. Observation of Clinical Efficacy on Oral or IV MTX in Treatment of Psoriasis[J]. The Chinese Journal of Dermatovenereology, 2006, 20(7): 416-417
Authors:LUO Quan  LI Chang-xing  HE Yu-qing  et al
Affiliation:Guangzhou Institute of Dermatology, Ghangzhou 510095, China
Abstract:
Objective To evaluate the efficacy and safety of two ways of methotrexate(MTX) for the treatment of psoriasis.Methods 68 patients with psoriasis were randomly divided into two groups,oral group:MTX 2.5-5.0 mg,tab per 12 h,3 times per week;intravenous group:7.5-15.0 mg,one time every week.Results There were no statistically significant differences between the two groups in terms of clinical efficacy(P>0.05).Adverse effects were lower and mild in the oral group.Conclusion The study indicates that two ways of treatment are effective for psoriasis,and the oral treatment has lower side effects.
Keywords:Psoriasis   Methotrexate
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号